final draft version of the report ready to go to layout
still have to work on the figures a little bit
I added a shorter executive summary (!ok?)
In the Annex, I deleted the column with the names of the companies - the most important are named in the text anyway.
the executive summary really improves the report.
i wonder, if it's really necessary to delete the column with the names of the companies since this is just "raw data" which is available for everyone who does patent-research. i mean, there's no judgment or the like in it, isnt't it? Or is it also possible to get SLAPPed for that?
(few minor corrections)
best matthias
Am 25.02.2021 um 18:56 schrieb Christoph Then:
still have to work on the figures a little bit
I added a shorter executive summary (!ok?)
In the Annex, I deleted the column with the names of the companies - the most important are named in the text anyway.
Npos_2018 mailing list Npos_2018@testbiotech.de https://lists.testbiotech.de/cgi-bin/mailman/listinfo/npos_2018
the executive summary really improves the report.
i wonder, if it's really necessary to delete the column with the names of the companies since this is just "raw data" which is available for everyone who does patent-research. i mean, there's no judgment or the like in it, isnt't it? Or is it also possible to get SLAPPed for that?
(few minor corrections)
best matthias
Am 25.02.2021 um 18:56 schrieb Christoph Then:
still have to work on the figures a little bit
I added a shorter executive summary (!ok?)
In the Annex, I deleted the column with the names of the companies - the most important are named in the text anyway.
Npos_2018 mailing list Npos_2018@testbiotech.de https://lists.testbiotech.de/cgi-bin/mailman/listinfo/npos_2018
Thanks Christoph.
Some suggestions on the executive summary and a few other small clarificatory questions from me.
Best Katherine
Von: Npos_2018 [mailto:npos_2018-bounces@testbiotech.de] Im Auftrag von Matthias Juhas Gesendet: Montag, 1. März 2021 17:41 An: npos_2018@testbiotech.de Betreff: Re: [Npos_2018] final draft version of the report ready to go to layout
the executive summary really improves the report.
i wonder, if it's really necessary to delete the column with the names of the companies since this is just "raw data" which is available for everyone who does patent-research. i mean, there's no judgment or the like in it, isnt't it? Or is it also possible to get SLAPPed for that?
(few minor corrections)
best matthias Am 25.02.2021 um 18:56 schrieb Christoph Then:
still have to work on the figures a little bit
I added a shorter executive summary (!ok?)
In the Annex, I deleted the column with the names of the companies - the
most important are named in the text anyway.
_______________________________________________
Npos_2018 mailing list
Npos_2018@testbiotech.demailto:Npos_2018@testbiotech.de
https://lists.testbiotech.de/cgi-bin/mailman/listinfo/npos_2018
--
Dr. Matthias Juhas
Gen-ethisches Netzwerk e.V. (GeN)
Stephanstraße 13
10559 Berlin
Tel. 030-685 7073
Fax: 030-684 1183
eMail: matthias.juhas@gen-ethisches-netzwerk.demailto:matthias.juhas@gen-ethisches-netzwerk.de
Web: www.gen-ethisches-netzwerk.dehttp://www.gen-ethisches-netzwerk.de
Twitter: @GeNetzwerk
Thank you,
perfect!
Ruth
Am 02.03.2021 um 13:58 schrieb ARCHE NOAH Katherine Dolan:
Thanks Christoph.
Some suggestions on the executive summary and a few other small clarificatory questions from me.
Best
Katherine
*Von:*Npos_2018 [mailto:npos_2018-bounces@testbiotech.de] *Im Auftrag von *Matthias Juhas *Gesendet:* Montag, 1. März 2021 17:41 *An:* npos_2018@testbiotech.de *Betreff:* Re: [Npos_2018] final draft version of the report ready to go to layout
the executive summary really improves the report.
i wonder, if it's really necessary to delete the column with the names of the companies since this is just "raw data" which is available for everyone who does patent-research. i mean, there's no judgment or the like in it, isnt't it? Or is it also possible to get SLAPPed for that?
(few minor corrections)
best matthias
Am 25.02.2021 um 18:56 schrieb Christoph Then:
still have to work on the figures a little bit I added a shorter executive summary (!ok?) In the Annex, I deleted the column with the names of the companies - the most important are named in the text anyway. _______________________________________________ Npos_2018 mailing list Npos_2018@testbiotech.de <mailto:Npos_2018@testbiotech.de> https://lists.testbiotech.de/cgi-bin/mailman/listinfo/npos_2018 <https://lists.testbiotech.de/cgi-bin/mailman/listinfo/npos_2018>-- Dr. Matthias Juhas Gen-ethisches Netzwerk e.V. (GeN) Stephanstraße 13 10559 Berlin Tel. 030-685 7073 Fax: 030-684 1183 eMail:matthias.juhas@gen-ethisches-netzwerk.de mailto:matthias.juhas@gen-ethisches-netzwerk.de Web:www.gen-ethisches-netzwerk.de http://www.gen-ethisches-netzwerk.de Twitter: @GeNetzwerk
Npos_2018 mailing list Npos_2018@testbiotech.de https://lists.testbiotech.de/cgi-bin/mailman/listinfo/npos_2018
participants (4)
-
ARCHE NOAH Katherine Dolan -
Christoph Then -
Matthias Juhas -
Ruth Tippe